⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2928808 | 0.96 | — | — | |
| SCHEMBL732537 | 0.69 | — | — | |
| SCHEMBL4554124 | 0.67 | — | — | |
| SCHEMBL11044810 | 0.67 | — | — | |
| SCHEMBL669011 | 0.65 | — | — | |
| SCHEMBL20916750 | 0.65 | — | — | |
| SCHEMBL2928805 | 0.65 | — | — | |
| SCHEMBL4187600 | 0.65 | — | — | |
| SCHEMBL18232769 | 0.63 | — | — | |
| SCHEMBL16500032 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2120905-A1 | METHODS, COMPOUNDS, AND COMPOSITIONS FOR TREATING METABOLIC DISORDERS AND DIABETES | BELLUS Health (International) Limited (CH) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008078176-A1 | METHODS, COMPOUNDS, AND COMPOSITIONS FOR TREATING METABOLIC DISORDERS AND DIABETES | BELLUS HEALTH (INTERNATIONAL) LIMITED (US) | 2008-07-03 | — | — | WO | disclosed |